首页|通心络胶囊治疗心力衰竭的潜在作用机制

通心络胶囊治疗心力衰竭的潜在作用机制

扫码查看
目的:基于网络药理学及分子对接技术探讨通心络胶囊治疗心力衰竭的潜在作用机制。方法:在《中国药典》中寻找通心络胶囊的主要中药成分,利用TCMSP数据库和BATMAN-TCM数据库系统提取中药成分对应的活性成分及靶点,导入Cytoscape 3。8。2软件中构建"中药-活性成分-靶点"图。在GeneCards、OMIM和TTD数据库中检索"心力衰竭"对应的靶点数据,并与通心络胶囊的治疗靶点取交集,利用STRING构建蛋白质互作网络图,利用David数据库进行基因本体(GO)、京都基因与基因组百科全书(KEGG)富集分析,筛选出排名居前20位的通路、活性成分及靶点,使用DockThor网站进行分子对接。结果:通心络胶囊的活性成分包括西红花素、异黄蝶呤、D-甘露醇、熊果酸等;可能通过钙离子信号通路、环磷酸腺苷(cAMP)信号通路、白介素17(IL-17)信号通路、肿瘤坏死因子(TNF)信号通路、C型凝集素受体信号通路等,作用于氨酸/苏氨酸蛋白激酶B(AKT1)、V-Rel网状内皮增生病毒癌基因同源物A重组蛋白(RELA)、环氧合酶2(PTGS2)、丝裂原激活蛋白激酶14(MAPK14)、丝裂原激活蛋白激酶1(MAPK1)、B细胞κ轻肽基因增强子核因子1(NFKB1)等关键靶点,达到治疗心力衰竭的目的。结论:通心络胶囊治疗心力衰竭具有多组分、多靶点、多通路协同的优势。
Potential Mechanism of Tongxinluo Capsules for the Treatment of Heart Failure
Objective:To explore the potential mechanism of Tongxinluo capsules for treating heart failure based on network pharmacology and molecular docking technology.Methods:The main traditional Chinese medicine components of Tongxinuo capsules were searched from Chinese Pharmacopoeia,and the corresponding active components and their targets were extracted using TCMSP database and BATMAN-TCM database system,and imported into Cytoscape 3. 8. 2 software to construct the "traditional Chinese medicine-active ingredient-target" diagram. Target data of "heart failure" were retrieved from GeneCards,OMIM and TTD databases,and the intersection was performed with the therapeutic target of Tongxinluo capsules.Protein interaction network diagram was constructed using STRING,and gene ontology(GO),Kyoto Encyclopedia of Genes and Genomes(KEGG) enrichment analysis were conducted using David database. The top 20 ranked pathways,active ingredients and targets were screened,and molecular docking were performed using DockThor website. Results:The active ingredients of Tongxinluo capsules included crocin,isoxanthopterin,D-mannitol,ursolic acid.It related through calcium ion signaling pathway,cyclic adenosine phosphate(cAMP) signaling pathway,interleukin-17(IL-17) signaling pathway,tumor necrosis factor(TNF) signaling pathway,C-type lectin receptor signaling pathway,acting on serine/threonine protein kinase B ( AKT1),recombinant protein A ( RELA),cyclooxygenase-2 ( PTGS2),mitogen-activated protein kinase 14(MAPK14),mitogen-activated protein kinase 1(MAPK1),and enhancer nuclear factor 1 of B cell κ light peptide gene(NFKB1) and other key targets for the treatment of heart failure.Conclusion:Tongxinluo capsules showed the advantages of multi-component,multi-target and multi-pathway synergism for the treatment of heart failure.

heart failureTongxinluo capsulesnetwork pharmacologymolecular dockingursolic acidmechanism

薛晶鑫、周华

展开 >

山西医科大学 太原 030001

山西医科大学第二医院 太原 030001

心力衰竭 通心络胶囊 网络药理学 分子对接 熊果酸 作用机制

2024

中西医结合心脑血管病杂志
中国中西医结合学会 山西医科大学第一医院

中西医结合心脑血管病杂志

CSTPCD
影响因子:1.463
ISSN:1672-1349
年,卷(期):2024.22(22)